Meeting
2018 ASCO Annual Meeting
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib.
Authors
Pashalina Kehagias
Gastro-Oncology Translational Laboratory, Institut Jules Bordet - Université Libre de Bruxelles (ULB), Brussels, Belgium
Pashalina Kehagias , Caroline Vandeputte , Lieveke Ameye , Hakim El Housni Sr., Amélie Deleporte , Karen Paula Geboes , Thierry Delaunoit Sr., Marc Peeters , Gauthier Demolin , Lionel A. D'Hondt , Jozef Janssens , Javier Carrasco , Stephane Holbrechts , Jean-Charles Goeminne , Philippe Vergauwe , Jean-Luc Van Laethem , Ghanem Ghanem , Marianne Paesmans , Patrick Flamen , Alain Hendlisz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Clinical Trial Registration Number
NCT01929616
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3532)
DOI
10.1200/JCO.2018.36.15_suppl.3532
Abstract #
3532
Poster Bd #
25
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prospective observational study of monitoring gene alterations in plasma cell-free DNA using droplet digital PCR system during anti-EGFR antibody treatment in patients with RAS wild-type advanced colorectal cancer.
First Author: Naoki Takahashi
Poster
2021 Gastrointestinal Cancers Symposium
Characteristics of genomic alterations in circulating tumor DNA (ctDNA) in patients (Pts) with advanced gastrointestinal (GI) cancers in nationwide large-scale ctDNA screening: SCRUM-Japan Monstar-Screen.
First Author: Yoshiaki Nakamura
Poster
2016 Gastrointestinal Cancers Symposium
Hypermethylated circulating DNA detection using picoliter droplet-based PCR in colorectal cancer.
First Author: Geraldine Perkins
Poster
2015 ASCO Annual Meeting
Low frequency KRAS G12/13 mutations in urine cell-free (cf) DNA from patients with BRAF V600E-mutant advanced cancers.
First Author: Filip Janku